A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides

Mihaela Perić(University of Zagreb), Radan Spaventi(Ruđer Bošković Institute), Albane Kessler(Centre National de la Recherche Scientifique), Íñigo Angulo‐Barturen(Euskadiko Parke Teknologikoa), Andrea Fajdetić(Pliva (Croatia)), Jasna Padovan(Pliva (Croatia)), Mirjana Bukvić(Pliva (Croatia)), Dijana Pešić(Pliva (Croatia)), Vesna Munić Kos(Karolinska Institutet), Mihailo Banjanac(Pliva (Croatia)), Maria Santos Martínez(GlaxoSmithKline (Spain)), Amanda Mathis(Research Triangle Park Foundation), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), Vesna Eraković Haber(Pliva (Croatia)), Sulejman Alihodžić(Pliva (Croatia)), Vlatka Bencetić Mihaljević(Pliva (Croatia)), Santiago Ferrer(GlaxoSmithKline (Spain)), Francisco‐Javier Gamo(GlaxoSmithKline (France)), María Belén Jiménez‐Díaz(GlaxoSmithKline (Spain)), Esperanza Herreros(GlaxoSmithKline (Spain))
British Journal of Pharmacology
October 21, 2020
Cited by 10


Related Papers